Medicine guide
WELIREG
As listed in the register: WELIREG 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
40 mg · comprimido recubierto con película
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Belzutifán
- Made by
- Merck Sharp & Dohme B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupCancer treatments and immune-system medicinesL01XX74
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Merck Sharp & Dohme B.V. |
|---|---|
| Active substance | Belzutifán |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 40 mg |
| Form | comprimido recubierto con película |
| Classification | L01XX74 · Cancer treatments and immune-system medicines |
| Route | vía oral |
| Marketed | Yes, according to the register |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Driving | The regulator flags that this medicine can affect the ability to drive. |
| Name in the register | WELIREG 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA |
| Nº Registro | 1241893002 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.